Basel Medical Group Ltd Ordinary Shares
Basel Medical Group Ltd Ordinary Shares BMGL Peers
See (BMGL) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Healthcare Plans Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| BMGL | $2.93 | -37.66% | 55M | 32.56 | $0.09 | N/A |
| UNH | $313.52 | -1.56% | 284.4B | 13.12 | $23.89 | +2.68% |
| ANTM | $482.58 | +2.71% | 114.6B | 18.99 | $25.41 | +1.74% |
| ELV | $384.55 | -0.43% | 86.9B | 14.96 | $25.71 | +1.74% |
| CVS | $67.47 | +1.69% | 85.4B | 16.10 | $4.19 | +3.95% |
| CI | $317.38 | +0.64% | 84.8B | 17.57 | $18.06 | +1.84% |
| HUM | $235.23 | +0.11% | 28.4B | 16.60 | $14.17 | +1.51% |
| CNC | $55.19 | -0.34% | 27.5B | 8.14 | $6.78 | N/A |
| MOH | $298.17 | +1.60% | 16.2B | 14.47 | $20.61 | N/A |
| OSCR | $13.96 | -2.62% | 3.1B | 34.90 | $0.40 | N/A |
Stock Comparison
BMGL vs UNH Comparison
BMGL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BMGL stands at 55M. In comparison, UNH has a market cap of 284.4B. Regarding current trading prices, BMGL is priced at $2.93, while UNH trades at $313.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BMGL currently has a P/E ratio of 32.56, whereas UNH's P/E ratio is 13.12. In terms of profitability, BMGL's ROE is +0.32%, compared to UNH's ROE of +0.24%. Regarding short-term risk, BMGL is more volatile compared to UNH. This indicates potentially higher risk in terms of short-term price fluctuations for BMGL.
BMGL vs ANTM Comparison
BMGL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BMGL stands at 55M. In comparison, ANTM has a market cap of 114.6B. Regarding current trading prices, BMGL is priced at $2.93, while ANTM trades at $482.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BMGL currently has a P/E ratio of 32.56, whereas ANTM's P/E ratio is 18.99. In terms of profitability, BMGL's ROE is +0.32%, compared to ANTM's ROE of +0.14%. Regarding short-term risk, BMGL is more volatile compared to ANTM. This indicates potentially higher risk in terms of short-term price fluctuations for BMGL.
BMGL vs ELV Comparison
BMGL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BMGL stands at 55M. In comparison, ELV has a market cap of 86.9B. Regarding current trading prices, BMGL is priced at $2.93, while ELV trades at $384.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BMGL currently has a P/E ratio of 32.56, whereas ELV's P/E ratio is 14.96. In terms of profitability, BMGL's ROE is +0.32%, compared to ELV's ROE of +0.14%. Regarding short-term risk, BMGL is more volatile compared to ELV. This indicates potentially higher risk in terms of short-term price fluctuations for BMGL.
BMGL vs CVS Comparison
BMGL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BMGL stands at 55M. In comparison, CVS has a market cap of 85.4B. Regarding current trading prices, BMGL is priced at $2.93, while CVS trades at $67.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BMGL currently has a P/E ratio of 32.56, whereas CVS's P/E ratio is 16.10. In terms of profitability, BMGL's ROE is +0.32%, compared to CVS's ROE of +0.07%. Regarding short-term risk, BMGL is more volatile compared to CVS. This indicates potentially higher risk in terms of short-term price fluctuations for BMGL.
BMGL vs CI Comparison
BMGL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BMGL stands at 55M. In comparison, CI has a market cap of 84.8B. Regarding current trading prices, BMGL is priced at $2.93, while CI trades at $317.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BMGL currently has a P/E ratio of 32.56, whereas CI's P/E ratio is 17.57. In terms of profitability, BMGL's ROE is +0.32%, compared to CI's ROE of +0.12%. Regarding short-term risk, BMGL is more volatile compared to CI. This indicates potentially higher risk in terms of short-term price fluctuations for BMGL.
BMGL vs HUM Comparison
BMGL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BMGL stands at 55M. In comparison, HUM has a market cap of 28.4B. Regarding current trading prices, BMGL is priced at $2.93, while HUM trades at $235.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BMGL currently has a P/E ratio of 32.56, whereas HUM's P/E ratio is 16.60. In terms of profitability, BMGL's ROE is +0.32%, compared to HUM's ROE of +0.10%. Regarding short-term risk, BMGL is more volatile compared to HUM. This indicates potentially higher risk in terms of short-term price fluctuations for BMGL.
BMGL vs CNC Comparison
BMGL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BMGL stands at 55M. In comparison, CNC has a market cap of 27.5B. Regarding current trading prices, BMGL is priced at $2.93, while CNC trades at $55.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BMGL currently has a P/E ratio of 32.56, whereas CNC's P/E ratio is 8.14. In terms of profitability, BMGL's ROE is +0.32%, compared to CNC's ROE of +0.13%. Regarding short-term risk, BMGL is more volatile compared to CNC. This indicates potentially higher risk in terms of short-term price fluctuations for BMGL.
BMGL vs MOH Comparison
BMGL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BMGL stands at 55M. In comparison, MOH has a market cap of 16.2B. Regarding current trading prices, BMGL is priced at $2.93, while MOH trades at $298.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BMGL currently has a P/E ratio of 32.56, whereas MOH's P/E ratio is 14.47. In terms of profitability, BMGL's ROE is +0.32%, compared to MOH's ROE of +0.26%. Regarding short-term risk, BMGL is more volatile compared to MOH. This indicates potentially higher risk in terms of short-term price fluctuations for BMGL.
BMGL vs OSCR Comparison
BMGL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BMGL stands at 55M. In comparison, OSCR has a market cap of 3.1B. Regarding current trading prices, BMGL is priced at $2.93, while OSCR trades at $13.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BMGL currently has a P/E ratio of 32.56, whereas OSCR's P/E ratio is 34.90. In terms of profitability, BMGL's ROE is +0.32%, compared to OSCR's ROE of +0.11%. Regarding short-term risk, BMGL is more volatile compared to OSCR. This indicates potentially higher risk in terms of short-term price fluctuations for BMGL.
BMGL vs ALHC Comparison
BMGL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BMGL stands at 55M. In comparison, ALHC has a market cap of 3B. Regarding current trading prices, BMGL is priced at $2.93, while ALHC trades at $14.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BMGL currently has a P/E ratio of 32.56, whereas ALHC's P/E ratio is -31.81. In terms of profitability, BMGL's ROE is +0.32%, compared to ALHC's ROE of -0.81%. Regarding short-term risk, BMGL is more volatile compared to ALHC. This indicates potentially higher risk in terms of short-term price fluctuations for BMGL.
BMGL vs CLOV Comparison
BMGL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BMGL stands at 55M. In comparison, CLOV has a market cap of 1.5B. Regarding current trading prices, BMGL is priced at $2.93, while CLOV trades at $2.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BMGL currently has a P/E ratio of 32.56, whereas CLOV's P/E ratio is -72.12. In terms of profitability, BMGL's ROE is +0.32%, compared to CLOV's ROE of -0.07%. Regarding short-term risk, BMGL is more volatile compared to CLOV. This indicates potentially higher risk in terms of short-term price fluctuations for BMGL.
BMGL vs BHG Comparison
BMGL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BMGL stands at 55M. In comparison, BHG has a market cap of 130.5M. Regarding current trading prices, BMGL is priced at $2.93, while BHG trades at $16.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BMGL currently has a P/E ratio of 32.56, whereas BHG's P/E ratio is -0.12. In terms of profitability, BMGL's ROE is +0.32%, compared to BHG's ROE of -0.47%. Regarding short-term risk, BMGL is more volatile compared to BHG. This indicates potentially higher risk in terms of short-term price fluctuations for BMGL.
BMGL vs MRAI Comparison
BMGL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BMGL stands at 55M. In comparison, MRAI has a market cap of 20.7M. Regarding current trading prices, BMGL is priced at $2.93, while MRAI trades at $1.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BMGL currently has a P/E ratio of 32.56, whereas MRAI's P/E ratio is -0.48. In terms of profitability, BMGL's ROE is +0.32%, compared to MRAI's ROE of +0.75%. Regarding short-term risk, BMGL is more volatile compared to MRAI. This indicates potentially higher risk in terms of short-term price fluctuations for BMGL.
BMGL vs IVF Comparison
BMGL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BMGL stands at 55M. In comparison, IVF has a market cap of 2.8M. Regarding current trading prices, BMGL is priced at $2.93, while IVF trades at $1.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BMGL currently has a P/E ratio of 32.56, whereas IVF's P/E ratio is -0.04. In terms of profitability, BMGL's ROE is +0.32%, compared to IVF's ROE of -2.58%. Regarding short-term risk, BMGL is more volatile compared to IVF. This indicates potentially higher risk in terms of short-term price fluctuations for BMGL.
BMGL vs NIVF Comparison
BMGL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BMGL stands at 55M. In comparison, NIVF has a market cap of 1.2M. Regarding current trading prices, BMGL is priced at $2.93, while NIVF trades at $1.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BMGL currently has a P/E ratio of 32.56, whereas NIVF's P/E ratio is -0.01. In terms of profitability, BMGL's ROE is +0.32%, compared to NIVF's ROE of +0.03%. Regarding short-term risk, BMGL is more volatile compared to NIVF. This indicates potentially higher risk in terms of short-term price fluctuations for BMGL.
BMGL vs GTS Comparison
BMGL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BMGL stands at 55M. In comparison, GTS has a market cap of 0. Regarding current trading prices, BMGL is priced at $2.93, while GTS trades at $35.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BMGL currently has a P/E ratio of 32.56, whereas GTS's P/E ratio is 10.41. In terms of profitability, BMGL's ROE is +0.32%, compared to GTS's ROE of +0.07%. Regarding short-term risk, BMGL is more volatile compared to GTS. This indicates potentially higher risk in terms of short-term price fluctuations for BMGL.
BMGL vs MGLN Comparison
BMGL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BMGL stands at 55M. In comparison, MGLN has a market cap of 0. Regarding current trading prices, BMGL is priced at $2.93, while MGLN trades at $94.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BMGL currently has a P/E ratio of 32.56, whereas MGLN's P/E ratio is 8.49. In terms of profitability, BMGL's ROE is +0.32%, compared to MGLN's ROE of +0.00%. Regarding short-term risk, BMGL is more volatile compared to MGLN. This indicates potentially higher risk in terms of short-term price fluctuations for BMGL.